norethindrone has been researched along with endothelin-1 in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 8 (88.89) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cacciatore, B; Paakkari, I; Tikkanen, MJ; Toivonen, J; Viinikka, L; Ylikorkala, O | 1 |
| Mikkola, T; Viinikka, L; Ylikorkala, O | 1 |
| Puolakka, J; Saltevo, J; Ylikorkala, O | 1 |
| Chondros, C; Christodoulakos, G; Creatsas, G; Dendrinos, S; Kouskouni, E; Panoulis, C | 1 |
| Altavilla, D; Corrado, F; Crisafulli, A; Cucinotta, D; D'Anna, R; Frisina, N; Morabito, N; Ruggeri, P; Saitta, A; Squadrito, F; Squadrito, G | 1 |
| Dalsgaard, T; Lund, CO; Nilas, L; Ottesen, B; Pedersen, NG; Pedersen, SH | 2 |
| Brook, RD; Duvernoy, CS; Kehrer, C; Kim, HM; Rose, PA | 1 |
| Nielsen, LB; Nilas, L; Ottesen, B; Pedersen, NG; Pedersen, SH | 1 |
6 trial(s) available for norethindrone and endothelin-1
| Article | Year |
|---|---|
The long-term effects of oral and transdermal postmenopausal hormone replacement therapy on nitric oxide, endothelin-1, prostacyclin, and thromboxane.
Topics: Administration, Cutaneous; Administration, Oral; Endothelin-1; Epoprostenol; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Nitric Oxide; Norethindrone; Norethindrone Acetate; Postmenopause; Prospective Studies; Thromboxanes | 1998 |
Administration of transdermal estrogen without progestin increases the capacity of plasma and serum to stimulate prostacyclin production in human vascular endothelial cells.
Topics: 6-Ketoprostaglandin F1 alpha; Administration, Cutaneous; Blood; Cells, Cultured; Endothelin-1; Endothelium, Vascular; Epoprostenol; Estradiol; Estrogen Replacement Therapy; Female; Follicle Stimulating Hormone; Humans; Norethindrone; Norethindrone Acetate; Postmenopause; Progestins; Prospective Studies; Umbilical Veins | 2000 |
Plasma endothelin in postmenopausal women with type 2 diabetes mellitus and metabolic syndrome: a comparison of oral combined and transdermal oestrogen-only replacement therapy.
Topics: Administration, Cutaneous; Administration, Oral; Biomarkers; Body Constitution; Body Mass Index; Cholesterol, HDL; Cross-Over Studies; Diabetes Mellitus, Type 2; Endothelin-1; Estradiol; Estrogen Replacement Therapy; Female; Humans; Hyperlipidemias; Hypertension; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Reference Values; Syndrome; Triglycerides | 2000 |
Effects of estrogen-progestin and raloxifene therapy on nitric oxide, prostacyclin and endothelin-1 synthesis.
Topics: Cardiovascular Diseases; Double-Blind Method; Endothelin-1; Epoprostenol; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Nitric Oxide; Norethindrone; Norethindrone Acetate; Placebos; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2002 |
Effect of genistein on endothelial function in postmenopausal women: a randomized, double-blind, controlled study.
Topics: Biomarkers; Brachial Artery; Double-Blind Method; Endothelin-1; Endothelium, Vascular; Estradiol; Estrogen Replacement Therapy; Female; Genistein; Humans; Middle Aged; Nitrates; Nitrites; Norethindrone; Norethindrone Acetate; Postmenopause; Time Factors; Vasodilation | 2003 |
Combined continuous ethinyl estradiol/norethindrone acetate does not improve forearm blood flow in postmenopausal women at risk for cardiovascular events: a pilot study.
Topics: Aged; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Endothelin-1; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Forearm; Humans; Middle Aged; Norethindrone; Pilot Projects; Plasminogen Activator Inhibitor 1; Postmenopause; Regional Blood Flow; Treatment Outcome; Vascular Cell Adhesion Molecule-1; Women's Health | 2007 |
3 other study(ies) available for norethindrone and endothelin-1
| Article | Year |
|---|---|
Different cerebrovascular effects of medroxyprogesterone acetate and norethisterone acetate in the New Zealand White rabbit.
Topics: Acetylcholine; Animals; Calcium; Cerebral Arteries; Constriction, Pathologic; Contraceptive Agents, Female; Endometrium; Endothelin-1; Enzyme Inhibitors; Estradiol; Estrogens; Estrogens, Conjugated (USP); Female; Medroxyprogesterone Acetate; Models, Animal; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Nitroprusside; Norethindrone; Norethindrone Acetate; Ovariectomy; Potassium; Rabbits; Random Allocation; Vasodilator Agents | 2004 |
Progestins used in hormonal replacement therapy display different effects in coronary arteries from New Zealand white rabbits.
Topics: Acetylcholine; Animals; Arteries; Calcium; Coronary Vessels; Disease Models, Animal; Endothelin-1; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Medroxyprogesterone Acetate; Menopause; NG-Nitroarginine Methyl Ester; Nitroprusside; Norethindrone; Norethindrone Acetate; Ovariectomy; Potassium; Progestins; Rabbits; Vasoconstriction; Vasodilation | 2004 |
Hormone therapy modulates ET(A) mRNA expression in the aorta of ovariectomised New Zealand White rabbits.
Topics: Animals; Aorta; Drug Combinations; Endothelin-1; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Gene Expression Regulation; Norethindrone; Norethindrone Acetate; Ovariectomy; Rabbits; RNA, Messenger | 2009 |